Skip to main content
. Author manuscript; available in PMC: 2009 Dec 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2008 Nov 24;17(12):3526–3535. doi: 10.1158/1055-9965.EPI-08-0424

Table 5.

Geometric means* (95% confidence limits) for total NNAL and 1-hydroxypyrene by nicotine metabolite ratio level

Nicotine Metabolite Ratio
P for trend§
Lower Tertile Second Tertile Upper Tertile

Total NNAL (pmol/mL) n Mean (95% CI) n Mean (95% CI) n Mean (95% CI)

All 193 0.70 (0.64–0.76) 192 0.79 (0.72–0.85) 193 0.80 (0.73–0.87) 0.03
Native Hawaiian 65 0.61 (0.53–0.71) 62 0.72 (0.62–0.84) 61 0.69 (0.59–0.81) 0.17
White 34 0.95 (0.78–1.16) 72 0.90 (0.79–1.03) 91 0.99 (0.88–1.12) 0.61
Japanese American 94 0.63 (0.56–0.71) 58 0.73 (0.63–0.86) 41 0.74 (0.62–0.89) 0.16

1-Hydroxypyrene (pmol/mL)
All 192 0.40 (0.31–0.51) 188 0.34 (0.26–0.43) 190 0.50 (0.39–0.65) 0.47
Native Hawaiian 65 0.37 (0.23–0.59) 60 0.35 (0.22–0.56) 60 0.50 (0.31–0.81) 0.65
White 34 0.40 (0.23–0.68) 71 0.31 (0.22–0.45) 90 0.52 (0.37–0.71) 0.58
Japanese American 93 0.42 (0.30–0.60) 57 0.35 (0.22–0.54) 40 0.52 (0.31–0.88) 0.54
*

Mean total NNAL (NNAL+NNAL-glucuronide) and mean 1-hydroxypyrene were adjusted for age, sex, cigarettes per day, and 12-hour urine volume by multiple covariance analysis.

Tertile categorization for nicotine metabolite ratio was based on all participants. First tertile: ≤ 0.484; second tertile: 0.484 to 1.10; third tertile: > 1.10.

Further adjusted for race.

§

P-values for trend were obtained by treating nicotine metabolite ratio as a continuous variable.